Now showing items 1-2 of 2

    • Article
      Icon

      The HLA-DQA1*05 genotype does not influence the clinical response to ustekinumab and vedolizumab 

      Navajas Hernández, Pilar; Pino Bellido, Pilar del; Lorenzo González, Laura; González Rodríguez, Concepción; Pérez Pérez, Antonio; Argüelles Arias, Federico (Aran Ediciones S.A., 2023)
      Background: the success of strategies with earlier anti-TNF drugs for the treatment of inflammatory bowel disease (IBD) ...
    • Article
      Icon

      Vedolizumab response in inflammatory bowel disease. Two years of follow-up 

      Belvis Jiménez, María Inmaculada; Pino Bellido, Pilar del; Castro Laria, Luisa; Maldonado Pérez, María Belén; Sáez Díaz, Antonia; Caunedo Álvarez, Ángel; Argüelles Arias, Federico (Aran Ediciones S.A., 2020)
      Background: vedolizumab is an α4β7 integrin antagonist. The aim of this study was to evaluate the clinical response and ...